Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
| 0P00007138 | CAD 54.94 0.18 0.33% |
About 61% of RBC Sciences' investor base is looking to short. The analysis of overall sentiment of trading RBC sciences biologiques fund suggests that many investors are alarmed at this time. The current market sentiment, together with RBC Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use RBC sciences biologiques fund news signals to limit their universe of possible portfolio assets.
RBC |
Merck , known as MSD outside of the United States and Canada, today announced the discontinuation of the clinical development programs for
Read at businesswire.com
 |
RBC Sciences Fundamental Analysis
We analyze RBC Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RBC Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RBC Sciences based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Minimum Initial Investment
Minimum Initial Investment Comparative Analysis
RBC Sciences is fourth largest fund in minimum initial investment among similar funds. Minimum Initial Investment refers to minimum amount the fund family or category will require an investor to deposit to acquire the very first position in the fund or to open an account. In other words, Minimum Initial Investment is a guarantee that any investment from a purchaser of a fund meets the minimum requirement of the fund.
RBC sciences biologiques Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with RBC Sciences fund to make a market-neutral strategy. Peer analysis of RBC Sciences could also be used in its relative valuation, which is a method of valuing RBC Sciences by comparing valuation metrics with similar companies.
Peers
RBC Sciences Related Equities
| 0P00007138 | RBC Sciences | 0.33 |
| ||
| 0P00018PVY | RBC European | 1.19 |
| ||
| 0P00007065 | RBC Mondial | 2.28 |
| ||
| 0P00007061 | RBC Canadian | 3.75 |
| ||
| 0P00012UCU | RBC Global | 9.73 |
| ||
| 0P000077P2 | RBC Dividend | 13.84 |
|
Other Information on Investing in RBC Fund
RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |